Senti Biosciences Inc. Insider Trading

SNTI

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

No executive or director has bought shares on the open market in the last two years.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

None

in the last two years

Get an email when SNTI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Feb 4, 2025 – Feb 6, 2025	Timothy K Lu CEO	SoldNo plan 2 parts	4,467	$4.11 average	18K	2.3%	Form 4
Feb 4, 2025 – Feb 6, 2025	Kanya Rajangam Pres. & Chief Med. & Dev. Off.	SoldNo plan 2 parts	1,479	$4.11 average	6K	15%	Form 4

Feb 4, 2025 – Feb 6, 2025No plan
Timothy K Lu
CEO · sold 4,467 at avg $4.11
18K
2.3% of stake
Feb 4, 2025 – Feb 6, 2025No plan
Kanya Rajangam
Pres. & Chief Med. & Dev. Off. · sold 1,479 at avg $4.11
6K
15% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SNTI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SNTI

CompareIntrinsic value

CELZCreative Medical Technology Holdings Inc.

$0.65-3.21%10

INMBInmune Bio Inc.

$1.33+0.76%10

AIMAIM ImmunoTech Inc.

$0.16+0.63%15

VIVSVivoSim Labs, Inc.

$0.15+8.71%10

ATYRAtyr Pharma Inc.

$6.18-6.79%10

WINTWindtree Therapeutics Inc.

$0.00+0.00%10

ZIVOZivo Bioscience Inc.

$8.00+10.34%0

JUNSJupiter Neurosciences Inc.

$2.46+1.23%10

Spot a number that looks wrong? Check it in SNTI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SNTI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.